approved EB-1A RFE Issued

Researcher

Internal Medicine · United Arab Emirates · 2025-06-09

Processing Time
116 days
Decision Date
2025-06-09
Location
Virginia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Original Contributions of Major Significance (Met)

The petitioner's work in tumor biology and cancer stem cells has guided global research trajectories in melanoma and bladder cancer therapy.

Authorship of Scholarly Articles (Met)

The petitioner authored 18 peer-reviewed articles in prestigious journals such as The Lancet and Cancers.

Judging the Work of Others (Met)

The petitioner completed over 18 manuscript reviews and serves on the editorial board of a peer-reviewed journal.

Why This Petition Was Approved

The petitioner satisfied three EB-1A criteria: original contributions of major significance, authorship of scholarly articles, and participation as a judge of others' work. Evidence included 18 peer-reviewed publications in top journals like The Lancet and over 200 citations from 37 countries. Additionally, the petitioner completed 18 manuscript reviews and serves on an editorial board.

Request for Evidence (RFE)

Successfully Addressed

The petition faced a Request for Evidence (RFE) which was successfully resolved by providing further documentation of the petitioner's global influence and track record.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
  • 18 peer-reviewed publications in journals including The Lancet, Cancers, and International Journal of Molecular Sciences
  • Over 200 citations from researchers in 37 countries
  • 18 manuscript reviews for respected medical journals
  • Editorial board membership for a peer-reviewed healthcare systems journal
  • Original contributions to cancer stem cell research and immune checkpoint inhibitor toxicities

Similar Cases

Research Scientist

Biotechnology · Turkey

WeGreened EB-1A approved
Utah 5 days 2025-04-02
The petition was approved based on meeting at least three EB-1A criteria, including authorship of 13 scholarly articles and 330 citations. The petitioner also demonstrated significant judging experience by reviewing 18 scholarly articles. Furthermore, the research was backed by prestigious funding from the NIH, DOD, and international foundations, proving the original and significant nature of his contributions.

Statistician

Research and Development · China

WeGreened EB-1A rfe approved
Kansas 503 days 2025-07-01
The petition was approved based on 25 peer-reviewed publications and one book chapter in high-impact journals like NEJM and JAMA, which garnered over 2,800 citations from 70 countries. The petitioner satisfied three EB-1A criteria: original scientific contributions, scholarly authorship, and judging the work of others. Additionally, the work was supported by funding from prominent agencies such as the NIH and NCI.

Postdoctoral Researcher

Biotechnology · Brazil

WeGreened EB-1A rfe approved
Maryland 98 days 2025-06-25
The petition was approved based on a record of 27 peer-reviewed publications in journals like Journal of Hepatology and Molecular Cell. The petitioner demonstrated impact through 255 citations from researchers in over 30 countries and the completion of at least 15 peer reviews. The evidence satisfied the EB-1A criteria for scholarly articles, judging, and original contributions of major significance.

Scientist

Research and Development · India

WeGreened EB-1A approved
Missouri 11 days 2024-02-06
The petitioner satisfied the EB-1A criteria through a record of 8 peer-reviewed journal articles, 3 preprints, and 2 conference abstracts which garnered 363 citations from researchers in 29 countries. Additionally, he completed 11 peer reviews, serving as a judge of the work of other experts. His research also received significant funding from major government bodies including the NIH and NCI.

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-09.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 116 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 5

EB-1A Case Data

Scraped Case Data

Total Cases 919
Success Rate 53.0%
Sustained 487
Dismissed 315

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist